Obtaining regulatory approval for small-molecule therapeutics continues to be an arduous and expensive process. Because composition of matter patents are often filed long before first-patient-in, that ...

In the continuing evolution of personalized medicine, a new study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with ...

The Wall Street Transcript is a completely unique resource for investors and business researchers.